Current Hepatitis C Vaccine Candidates Based on the Induction of Neutralizing Antibodies

The introduction of direct-acting antivirals (DAAs) has revolutionized hepatitis C treatment. Short courses of treatment with these drugs are highly beneficial to patients, eliminating hepatitis C virus (HCV) without adverse effects. However, this outstanding success is tempered by the continuing di...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomez-Escobar, Elsa, Roingeard, Philippe, Beaumont, Elodie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220683/
https://www.ncbi.nlm.nih.gov/pubmed/37243237
http://dx.doi.org/10.3390/v15051151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220683/
https://www.ncbi.nlm.nih.gov/pubmed/37243237
http://dx.doi.org/10.3390/v15051151

Ejemplares similares